Editorial Board: Arch Pharm (4/2021).
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202170008
- Publication type:
- Article
Works matching IS 03656233 AND DT 2021 AND VI 354 AND IP 4
Results: 14
1
2
Cover Picture: Arch Pharm (4/2021).
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202170007
- Publication type:
- Article
3
Natural cyclic polypeptides as vital phytochemical constituents from seeds of selected medicinal plants.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000446
- By:
- Publication type:
- Article
4
Molecular hydrogen (H<sub>2</sub>) as a potential treatment for acute and chronic fatigue.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000378
- By:
- Publication type:
- Article
5
Synthesis and in vitro carbonic anhydrases and acetylcholinesterase inhibitory activities of novel imidazolinone‐based benzenesulfonamides.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000375
- By:
- Publication type:
- Article
6
Derivatives of nitrogen mustard anticancer agents with improved cytotoxicity.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000366
- By:
- Publication type:
- Article
7
Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000351
- By:
- Publication type:
- Article
8
5‐Arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones with selective inhibitory activity against some leukemia cell lines.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000342
- By:
- Publication type:
- Article
9
Investigation of tyrosinase enzyme (from mushroom) inhibitory activities and antioxidant properties of new fluorine‐containing phthalocyanines.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000340
- By:
- Publication type:
- Article
10
Synthesis, molecular docking, and biological activities of new cyanopyridine derivatives containing phenylurea.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000334
- By:
- Publication type:
- Article
11
New indomethacin analogs as selective COX‐2 inhibitors: Synthesis, COX‐1/2 inhibitory activity, anti‐inflammatory, ulcerogenicity, histopathological, and docking studies.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000328
- By:
- Publication type:
- Article
12
Synthesis and antiseizure effect evaluation of nonimidazole histamine H<sub>3</sub> receptor antagonists containing the oxazole moiety.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000298
- By:
- Publication type:
- Article
13
Exploration of the nitrogen heterocyclic periphery around the core of the advanced FFA1 agonist fasiglifam (TAK‐875).
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000275
- By:
- Publication type:
- Article
14
Synthesis, structural characterization, and biological studies of ATBS–M complexes (M(II) = Cu, Co, Ni, and Mn): Access for promising antibiotics and anticancer agents.
- Published in:
- Archiv der Pharmazie, 2021, v. 354, n. 4, p. 1, doi. 10.1002/ardp.202000241
- By:
- Publication type:
- Article